🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,888 results for “1” Clear

  1. UB-221

    United Therapeutics Europe Ltd

    Chronic Idiopathic Urticaria

    phase 1 small molecule active

    1 trial

  2. UB-221

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Spontaneous Urticaria

    phase 1 mab active

    1 trial

  3. UB-221

    United Therapeutics Europe Ltd

    Urticaria Chronic

    phase 1 mab completed

    1 trial

  4. UB-312

    BRIGHT MINDS BIOSCIENCES INC.

    Parkinson's Disease

    phase 1 mab completed

    1 trial

  5. UB-421 SC

    United Therapeutics Europe Ltd

    HIV-1-infection

    phase 1 mab active

    1 trial

  6. UB-421 SC(dB4C7C22-6 mAb)

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 1 mab completed

    1 trial

  7. UB-621

    United Therapeutics Europe Ltd

    Herpes Simplex Virus Infection

    phase 1 small molecule completed

    1 trial

  8. UB-921

    United Therapeutics Europe Ltd

    Breast Neoplasm

    phase 1 mab completed

    1 trial

  9. UB-VV410

    The First People's Hospital of Lianyungang

    Systemic Lupus Erythematosus

    phase 1 small molecule active

    1 trial

  10. UI15AML055MT

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  11. UIC201602 and co-administration of UIC201601 and UIC201602

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  12. UP421

    Sana Biotechnology

    Type1diabetes

    phase 1 mab active

    1 trial

  13. UT-15C

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    2 trials

  14. UT-15C SR (treprostinil diethanolamine)

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule completed

    1 trial

  15. UTAA91 injection

    Suzhou Ribo Life Science Co.

    Rheumatoid Arthritis (RA)

    phase 1 mab active

    1 trial

  16. UTAA91 injection

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis (RA)

    phase 1 mab active

    1 trial

  17. UX-GIP001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epilepsy

    phase 1 small molecule active

    1 trial

  18. Ublituximab + TGR-1202

    TG THERAPEUTICS, INC.

    Chronic Lymphocytic Leukemia

    phase 1 small molecule completed

    1 trial

  19. Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health

    NovoThirteen

    Obesity, CCI, CCI

    phase 1 other active

    1 trial

  20. VCH 916

    Vertex Pharmaceuticals (Australia) Pty.

    HCV Infection

    phase 1 small molecule completed

    1 trial

  21. VCTX210A unit

    S.A.

    Diabetes Mellitus

    phase 1 other completed

    1 trial

  22. VCTX211

    S.A.

    Diabetes Mellitus

    phase 1 other terminated

    1 trial

  23. VGX-3100

    INOVIO PHARMACEUTICALS, INC.

    Papillomavirus Infections

    phase 1 mab completed

    1 trial

  24. VGX-3100

    INOVIO PHARMACEUTICALS, INC.

    Human Papillomavirus (HPV)

    phase 1 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources